MARLBOROUGH, Mass.--(BUSINESS WIRE)--
Hologic, Inc. ( HOLX ) announced today that a Massachusetts Superior Court granted a preliminary injunction in lawsuits against Chinese X-ray equipment provider Direct Digital Imaging Technology (Beijing), Inc. (DDIT) and a former Hologic employee, Lawrence Ibbetson, for alleged misappropriation of trade secrets.
Hologic alleges that DDIT and Ibbetson misappropriated trade secrets for selenium coating technology used in the detectors within Hologic's Selenia ® Dimensions ® and 3Dimensions ™ mammography systems. In 2016, Hologic filed suit against DDIT, alleging breach of contract for failure to pay for general radiography panels treated with Hologic’s proprietary coatings. In 2018, the complaint was amended to include trade secret misappropriation claims.
As part of the preliminary injunction, the Court ruled that Hologic is likely to succeed in its trade secret claims. As a result, the Court ordered the defendants to stop using or disclosing selenium coating specifications that Hologic alleges were wrongfully misappropriated. In addition, the defendants may not develop an alternative selenium coating unless certain conditions are met, including that the development be conducted under the watch of an independent monitor. The preliminary injunction is effective through the conclusion of a trial.
“We are very pleased with the Superior Court’s ruling," said Pete Valenti, President of Breast and Skeletal Health at Hologic. "As the world leader and innovator in mammography, we will continue to defend our intellectual property against what we believe to be unfair trade practices in order to protect the innovations that drive advances for our customers and outcomes for their patients.”
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com .
Hologic, 3D, 3Dimensions, Dimensions, Selenia, The Science of Sure, and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the likelihood of Hologic succeeding in its trade secret claims. There can be no assurance that Hologic will prevail at trial or in any appeal. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
SOURCE: Hologic, Inc.